IT1263144B - PHARMACEUTICAL COMPOSITIONS INCLUDING SPONGY MATERIAL CONSTITUTED FROM FOREIGN DERIVATIVES OF HYALURONIC ACID IN ASSOCIATION WITH OTHER PHARMACOLOGICALLY ACTIVE SUBSTANCES - Google Patents

PHARMACEUTICAL COMPOSITIONS INCLUDING SPONGY MATERIAL CONSTITUTED FROM FOREIGN DERIVATIVES OF HYALURONIC ACID IN ASSOCIATION WITH OTHER PHARMACOLOGICALLY ACTIVE SUBSTANCES

Info

Publication number
IT1263144B
IT1263144B ITMI930182A ITMI930182A IT1263144B IT 1263144 B IT1263144 B IT 1263144B IT MI930182 A ITMI930182 A IT MI930182A IT MI930182 A ITMI930182 A IT MI930182A IT 1263144 B IT1263144 B IT 1263144B
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
hyaluronic acid
active substances
pharmacologically active
association
Prior art date
Application number
ITMI930182A
Other languages
Italian (it)
Inventor
Lanfranco Callegaro
Original Assignee
Lanfranco Callegaro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lanfranco Callegaro filed Critical Lanfranco Callegaro
Priority to ITMI930182A priority Critical patent/IT1263144B/en
Publication of ITMI930182A0 publication Critical patent/ITMI930182A0/en
Priority to CA002155518A priority patent/CA2155518A1/en
Priority to AU60014/94A priority patent/AU6001494A/en
Priority to EP94906201A priority patent/EP0682534A1/en
Priority to KR1019950703218A priority patent/KR960700766A/en
Priority to JP6517622A priority patent/JPH08506497A/en
Priority to PCT/EP1994/000294 priority patent/WO1994017840A1/en
Publication of ITMI930182A1 publication Critical patent/ITMI930182A1/en
Application granted granted Critical
Publication of IT1263144B publication Critical patent/IT1263144B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invenzione si riferisce a nuove composizioni farmaceutiche comprendenti materiale spugnoso costituito da derivati esterei totali o parziali dell'acido ialuronico, da soli o in miscela tra loro, co-liofilizzato con una soluzione conte-nente altre sostanze farmacologicamente attive, al loro processo di produzione ed al loro impiego in chirurgia ed in particolare nella microchirurgia.The present invention relates to new pharmaceutical compositions comprising spongy material consisting of total or partial ester derivatives of hyaluronic acid, alone or in a mixture with each other, co-freeze-dried with a solution containing other pharmacologically active substances, to their process of production and their use in surgery and in particular in microsurgery.

ITMI930182A 1993-02-04 1993-02-04 PHARMACEUTICAL COMPOSITIONS INCLUDING SPONGY MATERIAL CONSTITUTED FROM FOREIGN DERIVATIVES OF HYALURONIC ACID IN ASSOCIATION WITH OTHER PHARMACOLOGICALLY ACTIVE SUBSTANCES IT1263144B (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
ITMI930182A IT1263144B (en) 1993-02-04 1993-02-04 PHARMACEUTICAL COMPOSITIONS INCLUDING SPONGY MATERIAL CONSTITUTED FROM FOREIGN DERIVATIVES OF HYALURONIC ACID IN ASSOCIATION WITH OTHER PHARMACOLOGICALLY ACTIVE SUBSTANCES
CA002155518A CA2155518A1 (en) 1993-02-04 1994-02-02 Pharmaceutical compositions comprising a spongy material consisting of ester derivatives of hyarulonic acid combined with other pharmacologically active substances
AU60014/94A AU6001494A (en) 1993-02-04 1994-02-02 Pharmaceutical compositions comprising a spongy material consisting of ester derivatives of hyaluronic acid combined with other pharmacologically active substances
EP94906201A EP0682534A1 (en) 1993-02-04 1994-02-02 Pharmaceutical compositions comprising a spongy material consisting of ester derivatives of hyaluronic acid combined with other pharmacologically active substances
KR1019950703218A KR960700766A (en) 1993-02-04 1994-02-02 Pharmaceutical composition consisting of sponge material in which ester derivative of hyaluronic acid is combined with other pharmaceutically effective substances
JP6517622A JPH08506497A (en) 1993-02-04 1994-02-02 Pharmaceutical composition comprising a sponge-like material consisting of an ester derivative of hyaluronic acid in combination with other pharmaceutically active substances
PCT/EP1994/000294 WO1994017840A1 (en) 1993-02-04 1994-02-02 Pharmaceutical compositions comprising a spongy material consisting of ester derivatives of hyaluronic acid combined with other pharmacologically active substances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI930182A IT1263144B (en) 1993-02-04 1993-02-04 PHARMACEUTICAL COMPOSITIONS INCLUDING SPONGY MATERIAL CONSTITUTED FROM FOREIGN DERIVATIVES OF HYALURONIC ACID IN ASSOCIATION WITH OTHER PHARMACOLOGICALLY ACTIVE SUBSTANCES

Publications (3)

Publication Number Publication Date
ITMI930182A0 ITMI930182A0 (en) 1993-02-04
ITMI930182A1 ITMI930182A1 (en) 1994-08-04
IT1263144B true IT1263144B (en) 1996-08-01

Family

ID=11364858

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI930182A IT1263144B (en) 1993-02-04 1993-02-04 PHARMACEUTICAL COMPOSITIONS INCLUDING SPONGY MATERIAL CONSTITUTED FROM FOREIGN DERIVATIVES OF HYALURONIC ACID IN ASSOCIATION WITH OTHER PHARMACOLOGICALLY ACTIVE SUBSTANCES

Country Status (7)

Country Link
EP (1) EP0682534A1 (en)
JP (1) JPH08506497A (en)
KR (1) KR960700766A (en)
AU (1) AU6001494A (en)
CA (1) CA2155518A1 (en)
IT (1) IT1263144B (en)
WO (1) WO1994017840A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997045532A1 (en) * 1996-05-28 1997-12-04 Brown University Research Foundation Hyaluronan based biodegradable scaffolds for tissue repair
US6596703B1 (en) 1997-07-11 2003-07-22 Jagotec Ag Promotion of wound healing utilizing steroids having reduced deteriorous systemic side effects typical of glucocorticoids, mineralocorticoids and sex steroids
US6872819B1 (en) * 1998-05-27 2005-03-29 Fidia Advanced Biopolymers S.R.L. Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells
WO2002045767A1 (en) * 2000-12-07 2002-06-13 Japan Tissue Engineering Co.,Ltd Substrate for tissue regeneration, material for transplantation, and processes for producing these
EP1369441A4 (en) 2001-01-31 2004-12-08 Seikagaku Kogyo Co Ltd Crosslinked polysaccharide sponge
US7238677B2 (en) 2003-03-28 2007-07-03 Kimberly-Clark Worldwide, Inc. Prevention of urogenital infections
WO2006005340A1 (en) * 2004-07-09 2006-01-19 Ferrosan A/S Haemostatic composition comprising hyaluronic acid
JP4754532B2 (en) * 2007-07-09 2011-08-24 生化学工業株式会社 A therapeutic agent containing hyaluronic acid oligosaccharide as an active ingredient
CN102014973A (en) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 Device for promotion of hemostasis and/or wound healing
CN104159527B (en) 2012-03-06 2017-04-12 弗罗桑医疗设备公司 Pressurized container containing haemostatic paste
CA2874290C (en) 2012-06-12 2020-02-25 Ferrosan Medical Devices A/S Dry haemostatic composition
AU2014283170B2 (en) 2013-06-21 2017-11-02 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
EP3470094B1 (en) 2013-12-11 2020-07-22 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
JP6726852B2 (en) 2014-10-13 2020-07-22 フェッローサン メディカル ディバイス エー／エス Dry composition for use in hemostasis and wound healing
CA2970710A1 (en) 2014-12-24 2016-06-30 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
RU2717356C2 (en) 2015-07-03 2020-03-23 Ферросан Медикал Дивайсиз А/С Syringe for holding vacuum in storage state
KR20210008479A (en) 2018-05-09 2021-01-22 훼로산 메디칼 디바이스 에이/에스 How to prepare a hemostatic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (en) * 1985-04-05 1991-07-17 Fidia Farmaceutici Topical compsn. contg. hyaluronic acid deriv. as vehicle
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1219587B (en) * 1988-05-13 1990-05-18 Fidia Farmaceutici SELF-CROSS-LINKED CARBOXYLY POLYSACCHARIDES
IT1248934B (en) * 1990-06-01 1995-02-11 Fidia Spa BIOCOMPATIBLE PERFORATED MEMBRANES, PROCESSES FOR THEIR PREPARATION, THEIR USE AS A SUPPORT FOR THE IN VITRO GROWTH OF EPITHELIAL CELLS, ARTIFICIAL LEATHER THUS OBTAINED AND THEIR USE IN LEATHER TRANSPLANTS
IT1247472B (en) * 1991-05-31 1994-12-17 Fidia Spa PROCESS FOR THE PREPARATION OF MICROSPHERES CONTAINING BIOLOGICALLY ACTIVE COMPONENTS.
IT1251151B (en) * 1991-08-05 1995-05-04 Fidia Spa SPONGY MATERIAL ESSENTIALLY CONSTITUTED BY HYALURONIC ACID, OR ITS DERIVATIVES
IT1260154B (en) * 1992-07-03 1996-03-28 Lanfranco Callegaro HYALURONIC ACID AND ITS DERIVATIVES IN INTERPENETRATING POLYMERS (IPN)

Also Published As

Publication number Publication date
CA2155518A1 (en) 1994-08-18
KR960700766A (en) 1996-02-24
WO1994017840A1 (en) 1994-08-18
ITMI930182A0 (en) 1993-02-04
EP0682534A1 (en) 1995-11-22
JPH08506497A (en) 1996-07-16
ITMI930182A1 (en) 1994-08-04
AU6001494A (en) 1994-08-29

Similar Documents

Publication Publication Date Title
IT1263144B (en) PHARMACEUTICAL COMPOSITIONS INCLUDING SPONGY MATERIAL CONSTITUTED FROM FOREIGN DERIVATIVES OF HYALURONIC ACID IN ASSOCIATION WITH OTHER PHARMACOLOGICALLY ACTIVE SUBSTANCES
FR2733427B1 (en) INJECTABLE BIPHASIC COMPOSITIONS CONTAINING HYALURONIC ACID, ESPECIALLY USEFUL IN REPAIRING AND AESTHETIC SURGERIES
CA2289717A1 (en) Novel therapy for constipation
DE69921941D1 (en) Process for the production of active pharmaceutical ingredient particles
BR9811827A (en) Aqueous aerosol preparations containing biologically active macromolecules and process for the production of corresponding aerosols
ES8507573A1 (en) Hyaluronic acid fractions having pharmaceutical activity, methods for preparation thereof, and pharmaceutical compositions containing the same.
DE3851152D1 (en) CYCLOSPORINE EYE PRODUCTS.
CA2258920A1 (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
MA26901A1 (en) NEW PHARMACEUTICAL COMPOSITION
IT8920170A0 (en) FLUORINATED DERIVATIVES OF BILE ACIDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ITMI920405A0 (en) POLYSACRIC DERIVATIVES OF HEPARIN EPARAN SULFATE THEIR FRACTIONS AND FRAGMENTS PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
ITMI931649A1 (en) DERIVATIVES OF 2-AMINO-4-PHENYL-4-BUTYRIC BONE ACID
IT1263013B (en) ESTERS OF L-CARNITINE AND ALCANOYL L-CARNITINE WITH GLYCOLIC ACID OR ITS ESTERS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH AS FOR THE TREATMENT OF SKIN DISEASES.
ATE239709T1 (en) RACEMIC HUPERZINE A
CA2161774A1 (en) Synthetic viscoelastic material for ophthalmic applications
BR9910329A (en) Compound, pharmaceutical composition, process to stimulate the release of growth hormone from a mammal's pituitary, and use of a compound
ATE254922T1 (en) PHARMACEUTICAL COMPOSITIONS HAVING ANTIMICROBIAL ACTION
CA2317465A1 (en) Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same
PT862575E (en) The invention relates to a process for preparing a pharmaceutical composition comprising
IT1251182B (en) DERMATAN SULPHATE OLIGOSACCHARIDES, PROCESS FOR THEIR PRODUCTION AND RELATED PHARMACEUTICAL COMPOSITIONS.
RU95113437A (en) Trans-2-dimethylamino-1-phenyl-3-cyclohexene-trans-1- carboxylic acid ±-ethyl ester as primary orthophosphate and solid pharmaceutical composition having pain-killing activity
RU94000064A (en) New 2-cyano-3-hydroxypropeneamides, method of preparing thereof, and pharmaceutical compositions containing said compounds
IT1231723B (en) PYROGLUTAMIC ACID DERIVATIVES, THEIR PREPARATIONS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IT1270008B (en) PURINIC AND 8-AZAPURINIC DERIVATIVES FOR THE THERAPEUTIC TREATMENT OF AIDS
ITMI930013A0 (en) DERIVATIVES OF 2-AZETIDINONE -1-SULFONIC ACID, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970227